![Sean Freeman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Freeman
Corporate Officer/Principal at
IRHYTHM HOLDINGS, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Sean Freeman is Executive VP-Strategy & Corporate Development at iRhythm Holdings, Inc. since 2025.
Former roles include Director at Molecular Assemblies, Inc., Head-Mergers & Acquisition at Life Technologies, Inc., and Senior VP-Strategy & Corporate Development at NuVasive LLC from 2015 to 2023.
Education includes an undergraduate degree from the University of the Witwatersrand and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-01 | 13,641 ( 0.04% ) | 2 M $ | 2026-05-30 |
Sean Freeman active positions
| Companies | Position | Start |
|---|---|---|
| IRHYTHM HOLDINGS, INC. | Corporate Officer/Principal | 2025-06-30 |
Former positions of Sean Freeman
| Companies | Position | End |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 2023-08-31 |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Develops, manufactures and supplies products used for life science research | Corporate Officer/Principal | - |
Molecular Assemblies, Inc.
 Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Director/Board Member | - |
Training of Sean Freeman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Develops, manufactures and supplies products used for life science research | Health Technology |
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
iRhythm Technologies, Inc.
 iRhythm Technologies, Inc. Medical SpecialtiesHealth Technology Provides monitoring and diagnostic solutions for detection of cardiac arrhythmias | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Health Technology |
- Stock Market
- Insiders
- Sean Freeman
Choose MarketScreener 
